No link between type I interferon autoantibody positivity and adverse reactions to COVID-19 vaccines
Description
Type I interferons act as gatekeepers against viral infection, and autoantibodies that neutralize these signaling molecules have been associated with COVID-19 severity and adverse reactions to the live-attenuated yellow fever vaccine. On this
